Literature DB >> 14655765

Differential expression of the chemokine receptors CX3CR1 and CCR1 by microglia and macrophages in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis.

Dan Sunnemark1, Sana Eltayeb, Erik Wallström, Lena Appelsved, Asa Malmberg, Hans Lassmann, Anders Ericsson-Dahlstrand, Fredrik Piehl, Tomas Olsson.   

Abstract

Chemokines are important for the recruitment of immune cells into sites of inflammation. To better understand their functional roles during inflammation we have here studied the in vivo expression of receptors for the chemokines CCL3/CCL5/CCL7 (MIP-1alpha/RANTES/MCP-3) and CX3CL1 (fractalkine), CCR1 and CX3CR1, respectively, in rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. Combined in situ hybridization and immunohistochemistry demonstrated intensely upregulated CCR1 mRNA expression in early, actively demyelinating plaques, whereas CX3CR1 displayed a more generalized expression pattern. CX3CR1 mRNA expressing cells were identified as microglia on the basis of their cellular morphology and positive GSA/B4 lectin staining. In contrast, CCR1 mRNA was preferentially expressed by ED1+ GSA/B4+ macrophages. The notion of differential chemokine receptor expression in microglia and monocyte-derived macrophages was corroborated at the protein level by extraction and flow cytometric sorting of cells infiltrating the spinal cord using gating for the surface markers CD45, ED-2 and CD11b. These observations suggest a differential receptor expression between microglia and monocyte-derived macrophages and that mainly the latter cell type is responsible for active demyelination. This has great relevance for the possibility of therapeutic intervention in demyelinating diseases such as multiple sclerosis, for example by targeting signaling events leading to monocyte recruitment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14655765     DOI: 10.1111/j.1750-3639.2003.tb00490.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  13 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

Review 2.  Age-related macular degeneration and the immune response: implications for therapy.

Authors:  Robert B Nussenblatt; Frederick Ferris
Journal:  Am J Ophthalmol       Date:  2007-08-15       Impact factor: 5.258

3.  Two-stage association study in Chinese Han identifies two independent associations in CCR1/CCR3 locus as candidate for Behçet's disease susceptibility.

Authors:  Shengping Hou; Xiang Xiao; Fuzhen Li; Zhengxuan Jiang; Aize Kijlstra; Peizeng Yang
Journal:  Hum Genet       Date:  2012-07-25       Impact factor: 4.132

4.  CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin.

Authors:  Dan Sunnemark; Sana Eltayeb; Maria Nilsson; Erik Wallström; Hans Lassmann; Tomas Olsson; Anna-Lena Berg; Anders Ericsson-Dahlstrand
Journal:  J Neuroinflammation       Date:  2005-07-29       Impact factor: 8.322

5.  Genetic regulation of microglia activation, complement expression, and neurodegeneration in a rat model of traumatic brain injury.

Authors:  Bo-Michael Bellander; Olle Lidman; Marcus Ohlsson; Britt Meijer; Fredrik Piehl; Mikael Svensson
Journal:  Exp Brain Res       Date:  2010-07-03       Impact factor: 1.972

6.  Early degeneration of photoreceptor synapse in Ccl2/Cx3cr1-deficient mice on Crb1(rd8) background.

Authors:  Jun Zhang; Jingsheng Tuo; Xiaoguan Cao; Defen Shen; Wei Li; Chi-Chao Chan
Journal:  Synapse       Date:  2013-05-27       Impact factor: 2.562

7.  Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration.

Authors:  Jingsheng Tuo; Christine M Bojanowski; Min Zhou; Defen Shen; Robert J Ross; Kevin I Rosenberg; D Joshua Cameron; Chunyue Yin; Jeffrey A Kowalak; Zhengping Zhuang; Kang Zhang; Chi-Chao Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

8.  Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis.

Authors:  Anna Ridderstad Wollberg; Anders Ericsson-Dahlstrand; Anders Juréus; Petra Ekerot; Sylvia Simon; Maria Nilsson; Stig-Johan Wiklund; Anna-Lena Berg; Mats Ferm; Dan Sunnemark; Rolf Johansson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-25       Impact factor: 11.205

9.  CCR1 Activation Promotes Neuroinflammation Through CCR1/TPR1/ERK1/2 Signaling Pathway After Intracerebral Hemorrhage in Mice.

Authors:  Jun Yan; Gang Zuo; Prativa Sherchan; Lei Huang; Umut Ocak; Weilin Xu; Zachary D Travis; Wenna Wang; John H Zhang; Jiping Tang
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

10.  Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.

Authors:  Sana Eltayeb; Anna-Lena Berg; Hans Lassmann; Erik Wallström; Maria Nilsson; Tomas Olsson; Anders Ericsson-Dahlstrand; Dan Sunnemark
Journal:  J Neuroinflammation       Date:  2007-05-07       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.